nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0466	0.0657	CbGbCtD
Candesartan—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0466	0.0657	CbGbCtD
Candesartan—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0383	0.0539	CbGbCtD
Candesartan—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.036	0.0506	CbGbCtD
Candesartan—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.036	0.0506	CbGbCtD
Candesartan—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0353	0.0498	CbGbCtD
Candesartan—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0353	0.0498	CbGbCtD
Candesartan—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0349	0.0491	CbGbCtD
Candesartan—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0339	0.0477	CbGbCtD
Candesartan—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0325	0.0458	CbGbCtD
Candesartan—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0325	0.0458	CbGbCtD
Candesartan—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0316	0.0444	CbGbCtD
Candesartan—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0281	0.0395	CbGbCtD
Candesartan—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0273	0.0384	CbGbCtD
Candesartan—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0272	0.0384	CbGbCtD
Candesartan—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0265	0.0372	CbGbCtD
Candesartan—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0247	0.0347	CbGbCtD
Candesartan—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0247	0.0347	CbGbCtD
Candesartan—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0239	0.0337	CbGbCtD
Candesartan—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0239	0.0337	CbGbCtD
Candesartan—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0236	0.0333	CbGbCtD
Candesartan—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0229	0.0323	CbGbCtD
Candesartan—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0177	0.025	CbGbCtD
Candesartan—AGTR1—endothelium—acquired immunodeficiency syndrome	0.00348	0.102	CbGeAlD
Candesartan—AGTR1—blood plasma—acquired immunodeficiency syndrome	0.00309	0.0904	CbGeAlD
Candesartan—UGT1A3—digestive system—acquired immunodeficiency syndrome	0.00279	0.0816	CbGeAlD
Candesartan—Pranlukast—TNF—acquired immunodeficiency syndrome	0.0021	0.661	CrCbGaD
Candesartan—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00167	0.049	CbGeAlD
Candesartan—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00153	0.0447	CbGeAlD
Candesartan—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00149	0.0435	CbGeAlD
Candesartan—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.00136	0.0397	CbGeAlD
Candesartan—AGTR1—lymphoid tissue—acquired immunodeficiency syndrome	0.0012	0.0352	CbGeAlD
Candesartan—AGTR1—blood—acquired immunodeficiency syndrome	0.00113	0.0331	CbGeAlD
Candesartan—AGTR1—vagina—acquired immunodeficiency syndrome	0.00105	0.0307	CbGeAlD
Candesartan—AGTR1—lung—acquired immunodeficiency syndrome	0.000992	0.029	CbGeAlD
Candesartan—AGTR1—nervous system—acquired immunodeficiency syndrome	0.000919	0.0269	CbGeAlD
Candesartan—AGTR1—central nervous system—acquired immunodeficiency syndrome	0.000885	0.0259	CbGeAlD
Candesartan—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000803	0.0235	CbGeAlD
Candesartan—Valsartan—ALB—acquired immunodeficiency syndrome	0.000724	0.228	CrCbGaD
Candesartan—AGTR1—brain—acquired immunodeficiency syndrome	0.000702	0.0205	CbGeAlD
Candesartan—AGTR1—lymph node—acquired immunodeficiency syndrome	0.000679	0.0199	CbGeAlD
Candesartan—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000653	0.0191	CbGeAlD
Candesartan—CYP2C8—blood—acquired immunodeficiency syndrome	0.000614	0.018	CbGeAlD
Candesartan—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000572	0.0167	CbGeAlD
Candesartan—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000569	0.0166	CbGeAlD
Candesartan—CYP2C9—blood—acquired immunodeficiency syndrome	0.000545	0.0159	CbGeAlD
Candesartan—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000522	0.0153	CbGeAlD
Candesartan—PTGS1—blood—acquired immunodeficiency syndrome	0.000498	0.0146	CbGeAlD
Candesartan—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000479	0.014	CbGeAlD
Candesartan—PTGS1—vagina—acquired immunodeficiency syndrome	0.000461	0.0135	CbGeAlD
Candesartan—ABCB1—retina—acquired immunodeficiency syndrome	0.00044	0.0129	CbGeAlD
Candesartan—PTGS1—lung—acquired immunodeficiency syndrome	0.000436	0.0128	CbGeAlD
Candesartan—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000404	0.0118	CbGeAlD
Candesartan—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000389	0.0114	CbGeAlD
Candesartan—CYP2C8—brain—acquired immunodeficiency syndrome	0.000381	0.0111	CbGeAlD
Candesartan—Losartan—ALB—acquired immunodeficiency syndrome	0.000353	0.111	CrCbGaD
Candesartan—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000313	0.00915	CbGeAlD
Candesartan—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000309	0.00904	CbGeAlD
Candesartan—PTGS1—brain—acquired immunodeficiency syndrome	0.000309	0.00903	CbGeAlD
Candesartan—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000298	0.00873	CbGeAlD
Candesartan—ABCB1—blood—acquired immunodeficiency syndrome	0.000294	0.00861	CbGeAlD
Candesartan—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000285	0.00833	CbGeAlD
Candesartan—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000283	0.00829	CbGeAlD
Candesartan—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000278	0.00112	CcSEcCtD
Candesartan—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000277	0.00111	CcSEcCtD
Candesartan—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000277	0.00111	CcSEcCtD
Candesartan—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000277	0.00111	CcSEcCtD
Candesartan—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000277	0.00111	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000276	0.00111	CcSEcCtD
Candesartan—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000276	0.00111	CcSEcCtD
Candesartan—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000276	0.00111	CcSEcCtD
Candesartan—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000276	0.00111	CcSEcCtD
Candesartan—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000276	0.00111	CcSEcCtD
Candesartan—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000276	0.00111	CcSEcCtD
Candesartan—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000275	0.00111	CcSEcCtD
Candesartan—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000273	0.0011	CcSEcCtD
Candesartan—ABCB1—vagina—acquired immunodeficiency syndrome	0.000273	0.00798	CbGeAlD
Candesartan—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000273	0.0011	CcSEcCtD
Candesartan—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000272	0.0011	CcSEcCtD
Candesartan—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000272	0.00109	CcSEcCtD
Candesartan—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000272	0.00109	CcSEcCtD
Candesartan—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000272	0.00109	CcSEcCtD
Candesartan—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00027	0.00109	CcSEcCtD
Candesartan—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00027	0.00108	CcSEcCtD
Candesartan—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000269	0.00108	CcSEcCtD
Candesartan—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.00108	CcSEcCtD
Candesartan—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000267	0.00107	CcSEcCtD
Candesartan—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000267	0.00107	CcSEcCtD
Candesartan—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000266	0.00107	CcSEcCtD
Candesartan—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000266	0.00107	CcSEcCtD
Candesartan—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000266	0.00107	CcSEcCtD
Candesartan—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.00107	CcSEcCtD
Candesartan—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000265	0.00107	CcSEcCtD
Candesartan—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000262	0.00105	CcSEcCtD
Candesartan—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000262	0.00105	CcSEcCtD
Candesartan—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000261	0.00105	CcSEcCtD
Candesartan—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000261	0.00105	CcSEcCtD
Candesartan—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.00105	CcSEcCtD
Candesartan—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000259	0.00104	CcSEcCtD
Candesartan—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000259	0.00104	CcSEcCtD
Candesartan—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000258	0.00104	CcSEcCtD
Candesartan—ABCB1—lung—acquired immunodeficiency syndrome	0.000258	0.00755	CbGeAlD
Candesartan—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000257	0.00104	CcSEcCtD
Candesartan—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000257	0.00103	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000257	0.00103	CcSEcCtD
Candesartan—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000256	0.00103	CcSEcCtD
Candesartan—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000256	0.00103	CcSEcCtD
Candesartan—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000255	0.00103	CcSEcCtD
Candesartan—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000255	0.00103	CcSEcCtD
Candesartan—Rash—Didanosine—acquired immunodeficiency syndrome	0.000253	0.00102	CcSEcCtD
Candesartan—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000253	0.00102	CcSEcCtD
Candesartan—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000253	0.00102	CcSEcCtD
Candesartan—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.00101	CcSEcCtD
Candesartan—Headache—Didanosine—acquired immunodeficiency syndrome	0.000252	0.00101	CcSEcCtD
Candesartan—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000251	0.00101	CcSEcCtD
Candesartan—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000251	0.00101	CcSEcCtD
Candesartan—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000251	0.00101	CcSEcCtD
Candesartan—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00025	0.00101	CcSEcCtD
Candesartan—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00025	0.001	CcSEcCtD
Candesartan—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00025	0.001	CcSEcCtD
Candesartan—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000249	0.001	CcSEcCtD
Candesartan—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000249	0.001	CcSEcCtD
Candesartan—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.001	CcSEcCtD
Candesartan—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000248	0.000998	CcSEcCtD
Candesartan—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000248	0.000997	CcSEcCtD
Candesartan—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000248	0.000995	CcSEcCtD
Candesartan—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000247	0.000994	CcSEcCtD
Candesartan—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000247	0.000992	CcSEcCtD
Candesartan—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000247	0.000991	CcSEcCtD
Candesartan—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000246	0.000991	CcSEcCtD
Candesartan—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000246	0.000989	CcSEcCtD
Candesartan—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000246	0.000989	CcSEcCtD
Candesartan—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000246	0.000989	CcSEcCtD
Candesartan—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000245	0.000985	CcSEcCtD
Candesartan—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.000985	CcSEcCtD
Candesartan—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000243	0.000979	CcSEcCtD
Candesartan—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000243	0.000977	CcSEcCtD
Candesartan—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000243	0.000977	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000243	0.000976	CcSEcCtD
Candesartan—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.000975	CcSEcCtD
Candesartan—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000242	0.000974	CcSEcCtD
Candesartan—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000241	0.000968	CcSEcCtD
Candesartan—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.000965	CcSEcCtD
Candesartan—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00024	0.000964	CcSEcCtD
Candesartan—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00024	0.000964	CcSEcCtD
Candesartan—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000239	0.000962	CcSEcCtD
Candesartan—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000239	0.000962	CcSEcCtD
Candesartan—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000239	0.00699	CbGeAlD
Candesartan—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000239	0.00096	CcSEcCtD
Candesartan—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000239	0.000959	CcSEcCtD
Candesartan—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.000958	CcSEcCtD
Candesartan—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000238	0.000958	CcSEcCtD
Candesartan—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000237	0.000955	CcSEcCtD
Candesartan—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.000954	CcSEcCtD
Candesartan—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000237	0.000952	CcSEcCtD
Candesartan—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.000951	CcSEcCtD
Candesartan—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.000951	CcSEcCtD
Candesartan—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.000951	CcSEcCtD
Candesartan—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000236	0.000948	CcSEcCtD
Candesartan—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000235	0.000945	CcSEcCtD
Candesartan—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000234	0.000943	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.000934	CcSEcCtD
Candesartan—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.00093	CcSEcCtD
Candesartan—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000231	0.00093	CcSEcCtD
Candesartan—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000231	0.000928	CcSEcCtD
Candesartan—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000231	0.000927	CcSEcCtD
Candesartan—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000231	0.000927	CcSEcCtD
Candesartan—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000925	CcSEcCtD
Candesartan—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00023	0.000925	CcSEcCtD
Candesartan—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.00023	0.00673	CbGeAlD
Candesartan—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00023	0.000923	CcSEcCtD
Candesartan—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00023	0.000923	CcSEcCtD
Candesartan—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000229	0.00092	CcSEcCtD
Candesartan—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.000916	CcSEcCtD
Candesartan—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000228	0.000916	CcSEcCtD
Candesartan—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000228	0.000915	CcSEcCtD
Candesartan—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000227	0.000914	CcSEcCtD
Candesartan—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000227	0.000914	CcSEcCtD
Candesartan—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000227	0.000911	CcSEcCtD
Candesartan—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000226	0.00091	CcSEcCtD
Candesartan—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.000908	CcSEcCtD
Candesartan—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.000908	CcSEcCtD
Candesartan—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.000908	CcSEcCtD
Candesartan—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.000905	CcSEcCtD
Candesartan—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000224	0.000902	CcSEcCtD
Candesartan—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000224	0.000901	CcSEcCtD
Candesartan—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000223	0.000896	CcSEcCtD
Candesartan—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000223	0.000896	CcSEcCtD
Candesartan—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000222	0.000894	CcSEcCtD
Candesartan—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000893	CcSEcCtD
Candesartan—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000222	0.000892	CcSEcCtD
Candesartan—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000221	0.000887	CcSEcCtD
Candesartan—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00022	0.000886	CcSEcCtD
Candesartan—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00022	0.000885	CcSEcCtD
Candesartan—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.000885	CcSEcCtD
Candesartan—Rash—Stavudine—acquired immunodeficiency syndrome	0.00022	0.000884	CcSEcCtD
Candesartan—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.000883	CcSEcCtD
Candesartan—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00022	0.000883	CcSEcCtD
Candesartan—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.000882	CcSEcCtD
Candesartan—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000219	0.000881	CcSEcCtD
Candesartan—Headache—Stavudine—acquired immunodeficiency syndrome	0.000218	0.000879	CcSEcCtD
Candesartan—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000218	0.000878	CcSEcCtD
Candesartan—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000218	0.000876	CcSEcCtD
Candesartan—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000217	0.000875	CcSEcCtD
Candesartan—Rash—Abacavir—acquired immunodeficiency syndrome	0.000217	0.000871	CcSEcCtD
Candesartan—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000216	0.00087	CcSEcCtD
Candesartan—Headache—Abacavir—acquired immunodeficiency syndrome	0.000215	0.000865	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.000863	CcSEcCtD
Candesartan—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000215	0.000863	CcSEcCtD
Candesartan—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000214	0.000862	CcSEcCtD
Candesartan—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.000852	CcSEcCtD
Candesartan—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.000852	CcSEcCtD
Candesartan—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.000851	CcSEcCtD
Candesartan—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.000851	CcSEcCtD
Candesartan—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000211	0.000847	CcSEcCtD
Candesartan—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000211	0.000847	CcSEcCtD
Candesartan—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.000845	CcSEcCtD
Candesartan—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.000842	CcSEcCtD
Candesartan—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000841	CcSEcCtD
Candesartan—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.000838	CcSEcCtD
Candesartan—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000208	0.000836	CcSEcCtD
Candesartan—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.000834	CcSEcCtD
Candesartan—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000207	0.000834	CcSEcCtD
Candesartan—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000207	0.000833	CcSEcCtD
Candesartan—AGTR1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.000207	0.0555	CbGpPWpGaD
Candesartan—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000831	CcSEcCtD
Candesartan—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000204	0.000821	CcSEcCtD
Candesartan—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.000819	CcSEcCtD
Candesartan—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.000818	CcSEcCtD
Candesartan—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.000817	CcSEcCtD
Candesartan—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.000814	CcSEcCtD
Candesartan—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000202	0.000813	CcSEcCtD
Candesartan—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000813	CcSEcCtD
Candesartan—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.000813	CcSEcCtD
Candesartan—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000811	CcSEcCtD
Candesartan—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.00081	CcSEcCtD
Candesartan—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.00081	CcSEcCtD
Candesartan—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.0002	0.000806	CcSEcCtD
Candesartan—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000803	CcSEcCtD
Candesartan—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000199	0.000802	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.000793	CcSEcCtD
Candesartan—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000787	CcSEcCtD
Candesartan—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000786	CcSEcCtD
Candesartan—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.000781	CcSEcCtD
Candesartan—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.000776	CcSEcCtD
Candesartan—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000193	0.000776	CcSEcCtD
Candesartan—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000193	0.000775	CcSEcCtD
Candesartan—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.000775	CcSEcCtD
Candesartan—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000774	CcSEcCtD
Candesartan—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000191	0.000769	CcSEcCtD
Candesartan—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000191	0.000768	CcSEcCtD
Candesartan—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000191	0.000768	CcSEcCtD
Candesartan—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000766	CcSEcCtD
Candesartan—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00019	0.000764	CcSEcCtD
Candesartan—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.000758	CcSEcCtD
Candesartan—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.000753	CcSEcCtD
Candesartan—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000751	CcSEcCtD
Candesartan—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.00075	CcSEcCtD
Candesartan—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000186	0.00075	CcSEcCtD
Candesartan—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.000749	CcSEcCtD
Candesartan—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.000749	CcSEcCtD
Candesartan—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000746	CcSEcCtD
Candesartan—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000183	0.000735	CcSEcCtD
Candesartan—ABCB1—brain—acquired immunodeficiency syndrome	0.000183	0.00534	CbGeAlD
Candesartan—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000182	0.000733	CcSEcCtD
Candesartan—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.000725	CcSEcCtD
Candesartan—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.000725	CcSEcCtD
Candesartan—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00018	0.000724	CcSEcCtD
Candesartan—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000721	CcSEcCtD
Candesartan—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000721	CcSEcCtD
Candesartan—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000179	0.000721	CcSEcCtD
Candesartan—Rash—Indinavir—acquired immunodeficiency syndrome	0.000178	0.000715	CcSEcCtD
Candesartan—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000178	0.000714	CcSEcCtD
Candesartan—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000712	CcSEcCtD
Candesartan—Headache—Indinavir—acquired immunodeficiency syndrome	0.000177	0.00071	CcSEcCtD
Candesartan—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000176	0.00516	CbGeAlD
Candesartan—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.000708	CcSEcCtD
Candesartan—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000174	0.000701	CcSEcCtD
Candesartan—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000691	CcSEcCtD
Candesartan—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000688	CcSEcCtD
Candesartan—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000688	CcSEcCtD
Candesartan—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000169	0.000681	CcSEcCtD
Candesartan—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.00068	CcSEcCtD
Candesartan—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.000678	CcSEcCtD
Candesartan—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.000675	CcSEcCtD
Candesartan—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.000675	CcSEcCtD
Candesartan—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000167	0.000673	CcSEcCtD
Candesartan—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.000671	CcSEcCtD
Candesartan—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.00067	CcSEcCtD
Candesartan—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000654	CcSEcCtD
Candesartan—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000162	0.000652	CcSEcCtD
Candesartan—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.000648	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.000161	0.043	CbGpPWpGaD
Candesartan—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.000646	CcSEcCtD
Candesartan—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.000646	CcSEcCtD
Candesartan—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000645	CcSEcCtD
Candesartan—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000642	CcSEcCtD
Candesartan—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000158	0.000636	CcSEcCtD
Candesartan—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.000627	CcSEcCtD
Candesartan—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000624	CcSEcCtD
Candesartan—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000624	CcSEcCtD
Candesartan—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000616	CcSEcCtD
Candesartan—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000609	CcSEcCtD
Candesartan—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000603	CcSEcCtD
Candesartan—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000603	CcSEcCtD
Candesartan—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.000598	CcSEcCtD
Candesartan—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000597	CcSEcCtD
Candesartan—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000595	CcSEcCtD
Candesartan—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000594	CcSEcCtD
Candesartan—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.00058	CcSEcCtD
Candesartan—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000575	CcSEcCtD
Candesartan—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000575	CcSEcCtD
Candesartan—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000575	CcSEcCtD
Candesartan—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000571	CcSEcCtD
Candesartan—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000563	CcSEcCtD
Candesartan—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000553	CcSEcCtD
Candesartan—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000549	CcSEcCtD
Candesartan—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000548	CcSEcCtD
Candesartan—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000545	CcSEcCtD
Candesartan—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000542	CcSEcCtD
Candesartan—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000517	CcSEcCtD
Candesartan—AGTR1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.000116	0.031	CbGpPWpGaD
Candesartan—AGTR1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.000109	0.0291	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000108	0.0289	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	0.000103	0.0276	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	9.74e-05	0.0261	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	8.81e-05	0.0236	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	8.21e-05	0.022	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	7.82e-05	0.021	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	7.82e-05	0.021	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	7.61e-05	0.0204	CbGpPWpGaD
Candesartan—AGTR1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	7.46e-05	0.02	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	7.44e-05	0.0199	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	6.57e-05	0.0176	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	6.53e-05	0.0175	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	6.02e-05	0.0161	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	5.91e-05	0.0158	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	5.83e-05	0.0156	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	5.44e-05	0.0146	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	5.12e-05	0.0137	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	5.12e-05	0.0137	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	4.97e-05	0.0133	CbGpPWpGaD
Candesartan—PTGS1—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	4.86e-05	0.013	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	4.6e-05	0.0123	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	4.5e-05	0.012	CbGpPWpGaD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—acquired immunodeficiency syndrome	4.29e-05	0.0115	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	4.26e-05	0.0114	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	4.25e-05	0.0114	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	4.21e-05	0.0113	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	4.09e-05	0.0109	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	4.04e-05	0.0108	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	4.01e-05	0.0107	CbGpPWpGaD
Candesartan—PTGS1—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	3.92e-05	0.0105	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	3.89e-05	0.0104	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	3.65e-05	0.00977	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	3.51e-05	0.00939	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	3.5e-05	0.00937	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	3.5e-05	0.00937	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	3.43e-05	0.00919	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	3.43e-05	0.00919	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	3.07e-05	0.00823	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	3.03e-05	0.00811	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	2.98e-05	0.00797	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	2.78e-05	0.00744	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	2.75e-05	0.00735	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.64e-05	0.00708	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	2.61e-05	0.007	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	2.61e-05	0.007	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	2.61e-05	0.00699	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	2.55e-05	0.00684	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	2.49e-05	0.00667	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—TAT—acquired immunodeficiency syndrome	2.46e-05	0.00658	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	2.41e-05	0.00646	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	2.35e-05	0.0063	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	2.31e-05	0.00618	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	2.3e-05	0.00615	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	2.3e-05	0.00615	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	2.23e-05	0.00598	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	2.2e-05	0.00589	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	2.18e-05	0.00585	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AGPS—acquired immunodeficiency syndrome	2.09e-05	0.00559	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	1.99e-05	0.00532	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	1.79e-05	0.0048	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.71e-05	0.00457	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.58e-05	0.00422	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.57e-05	0.00421	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.51e-05	0.00404	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.51e-05	0.00404	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.48e-05	0.00395	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.48e-05	0.00395	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.43e-05	0.00382	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	1.42e-05	0.00381	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.39e-05	0.00372	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—TAT—acquired immunodeficiency syndrome	1.38e-05	0.00371	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.36e-05	0.00365	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	1.35e-05	0.00362	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.34e-05	0.00359	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.34e-05	0.00359	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	1.2e-05	0.00321	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.18e-05	0.00315	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	1.15e-05	0.00308	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.12e-05	0.00301	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.11e-05	0.00296	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.08e-05	0.00289	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.02e-05	0.00273	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.01e-05	0.00271	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1e-05	0.00269	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.32e-06	0.0025	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.19e-06	0.00246	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	8.94e-06	0.00239	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	8.74e-06	0.00234	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.43e-06	0.00226	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.92e-06	0.00212	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.92e-06	0.00212	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	7.79e-06	0.00209	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	7.6e-06	0.00204	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	7.27e-06	0.00195	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	6.62e-06	0.00177	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	6.19e-06	0.00166	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.03e-06	0.00161	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.94e-06	0.00159	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.85e-06	0.00157	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.43e-06	0.00145	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	5.42e-06	0.00145	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.31e-06	0.00142	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	4.31e-06	0.00115	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ALB—acquired immunodeficiency syndrome	4.28e-06	0.00115	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.5e-06	0.000937	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.14e-06	0.00084	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.12e-06	0.000836	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.9e-06	0.000776	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.85e-06	0.000763	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALB—acquired immunodeficiency syndrome	2.41e-06	0.000646	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.84e-06	0.000494	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	1.56e-06	0.000417	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	1.36e-06	0.000364	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	1.27e-06	0.00034	CbGpPWpGaD
